1. Home
  2. LAUR vs BHVN Comparison

LAUR vs BHVN Comparison

Compare LAUR & BHVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LAUR
  • BHVN
  • Stock Information
  • Founded
  • LAUR 1989
  • BHVN 2013
  • Country
  • LAUR United States
  • BHVN United States
  • Employees
  • LAUR N/A
  • BHVN N/A
  • Industry
  • LAUR Other Consumer Services
  • BHVN Biotechnology: Pharmaceutical Preparations
  • Sector
  • LAUR Real Estate
  • BHVN Health Care
  • Exchange
  • LAUR Nasdaq
  • BHVN Nasdaq
  • Market Cap
  • LAUR 2.8B
  • BHVN 2.9B
  • IPO Year
  • LAUR 2017
  • BHVN 2017
  • Fundamental
  • Price
  • LAUR $20.45
  • BHVN $27.65
  • Analyst Decision
  • LAUR Buy
  • BHVN Strong Buy
  • Analyst Count
  • LAUR 2
  • BHVN 14
  • Target Price
  • LAUR $20.00
  • BHVN $63.15
  • AVG Volume (30 Days)
  • LAUR 826.6K
  • BHVN 1.2M
  • Earning Date
  • LAUR 05-01-2025
  • BHVN 03-03-2025
  • Dividend Yield
  • LAUR N/A
  • BHVN N/A
  • EPS Growth
  • LAUR 183.74
  • BHVN N/A
  • EPS
  • LAUR 1.92
  • BHVN N/A
  • Revenue
  • LAUR $1,566,642,000.00
  • BHVN N/A
  • Revenue This Year
  • LAUR $1.62
  • BHVN N/A
  • Revenue Next Year
  • LAUR $7.66
  • BHVN $379.76
  • P/E Ratio
  • LAUR $10.60
  • BHVN N/A
  • Revenue Growth
  • LAUR 5.55
  • BHVN N/A
  • 52 Week Low
  • LAUR $13.26
  • BHVN $26.57
  • 52 Week High
  • LAUR $21.73
  • BHVN $55.72
  • Technical
  • Relative Strength Index (RSI)
  • LAUR 61.26
  • BHVN 35.77
  • Support Level
  • LAUR $19.04
  • BHVN $28.22
  • Resistance Level
  • LAUR $20.83
  • BHVN $31.18
  • Average True Range (ATR)
  • LAUR 0.47
  • BHVN 1.56
  • MACD
  • LAUR 0.14
  • BHVN 0.20
  • Stochastic Oscillator
  • LAUR 84.68
  • BHVN 23.43

About LAUR Laureate Education Inc.

Laureate Education Inc is an international community of universities. The company provides higher education programs and services to students through an international network of licensed universities and higher education institutions. Its geographical segments include Peru and Mexico.

About BHVN Biohaven Ltd.

Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder, and others.

Share on Social Networks: